Exane Derivatives Biotechnology

Exane Derivatives

  • $157 Million
  • Q2 2022

Stock List

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$12.8B
$609,000 0.39% of portfolio
4,267
Q2 2022 Added 8.94%
$0
$152,000 0.1% of portfolio
864
Q2 2022 Reduced 41.26%
$2.38B
$141,000 0.09% of portfolio
407
Q1 2022 New
$5.84B
$122,000 0.08% of portfolio
1,707
Q1 2022 Reduced 10.91%
$13.2B
$122,000 0.08% of portfolio
1,473
Q2 2022 Reduced 22.02%
$23.1B
$119,000 0.08% of portfolio
799
Q2 2022 Added 13.49%
$244M
$94,000 0.06% of portfolio
11,141
Q2 2022 Added 89.67%
$0
$93,000 0.06% of portfolio
740
Q1 2022 Reduced 7.85%
$805M
$92,000 0.06% of portfolio
9,496
Q1 2022 Reduced 7.87%
$5.44B
$87,000 0.06% of portfolio
2,279
Q2 2022 Added 7,496.67%
$1.2B
$87,000 0.06% of portfolio
8,683
Q1 2022 Added 15.76%
$187M
$80,000 0.05% of portfolio
14,377
Q2 2022 New
$173B
$3,000 0.0% of portfolio
29
Q1 2018 Reduced 64.2%
$4.28B
$2,000 0.0% of portfolio
53
Q3 2021 Reduced 96.77%
$34B
$2,000 0.0% of portfolio
6
Q2 2022 Reduced 94.59%
$70.6B
$1,000 0.0% of portfolio
2
Q2 2022 Reduced 99.18%
$3.22B
$1,000 0.0% of portfolio
20
Q4 2021 Reduced 97.83%
$348M
$1,000 0.0% of portfolio
1,611
Q2 2022 Reduced 94.42%
$720M
$0 0.0% of portfolio
2,650
Q2 2022 Reduced 44.4%
$13M
$0 0.0% of portfolio
166
Q1 2020 Reduced 92.1%
$268M
$0 0.0% of portfolio
78
Q4 2021 Reduced 98.36%
$12M
$0 0.0% of portfolio
61
Q2 2021 New
$2.53B
$0 0.0% of portfolio
90
Q2 2020 Reduced 94.97%
$1.48B
$0 0.0% of portfolio
32
Q2 2022 Reduced 99.57%
$155M
$0 0.0% of portfolio
180
Q4 2019 Reduced 94.17%
$47.4M
$0 0.0% of portfolio
121
Q3 2018 Reduced 99.1%
$640M
$0 0.0% of portfolio
8
Q4 2021 Reduced 99.83%
$392M
$0 0.0% of portfolio
471
Q4 2018 New
$301M
$0 0.0% of portfolio
5
Q1 2019 Reduced 98.56%
$2.9B
$0 0.0% of portfolio
10
Q2 2022 Reduced 99.9%
$4.09B
$0 0.0% of portfolio
12
Q2 2022 Reduced 90.63%
$6.49B
$0 0.0% of portfolio
3
Q2 2022 Reduced 93.48%
$5.3B
$0 0.0% of portfolio
8
Q2 2022 Reduced 98.59%
$481M
$0 0.0% of portfolio
14
Q3 2021 Reduced 96.41%
$559M
$0 0.0% of portfolio
20
Q4 2019 Reduced 94.92%
$0
$0 0.0% of portfolio
6
Q4 2019 Reduced 99.84%
$70.6M
$0 0.0% of portfolio
14
Q3 2021 Reduced 99.63%
$34.5M
$0 0.0% of portfolio
48
Q2 2021 Reduced 94.24%
$0
$0 0.0% of portfolio
12
Q2 2022 Reduced 99.48%
$937M
$0 0.0% of portfolio
101
Q1 2021 Reduced 94.95%
Filter Shares Options
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email